Genome-wide association study of suicidal ideation emerging during citalopram treatment of depressed outpatients
about
Evaluating genetic markers and neurobiochemical analytes for fluoxetine response using a panel of mouse inbred strainsThe serotonergic system in mood disorders and suicidal behaviourGenetic Association Studies of Suicidal Behavior: A Review of the Past 10 Years, Progress, Limitations, and Future DirectionsGenomewide association scan of suicidal thoughts and behaviour in major depression"Gestaltomics": Systems Biology Schemes for the Study of Neuropsychiatric Diseases.IGENT: efficient entropy based algorithm for genome-wide gene-gene interaction analysis.Pharmacogenomics of suicidal events.Pharmacogenetics of antidepressant response.Genome-wide association studies in pharmacogenomics: successes and lessons.Understanding the pharmacogenetics of selective serotonin reuptake inhibitors.The molecular bases of the suicidal brain.Personalized medicine in psychiatry: problems and promises.Genetic relationships between suicide attempts, suicidal ideation and major psychiatric disorders: a genome-wide association and polygenic scoring study.Investigation of blood mRNA biomarkers for suicidality in an independent sampleShared genetic background for regulation of mood and sleep: association of GRIA3 with sleep duration in healthy Finnish women.The promise and reality of pharmacogenetics in psychiatryGenome-wide association study of antidepressant treatment-emergent suicidal ideation.Targeted Sequencing of FKBP5 in Suicide Attempters with Bipolar Disorder.A pilot genome wide association and gene expression array study of suicide with and without major depression.Genome-wide association study of personality traits in the long life family studyPharmacogenetics studies in STAR*D: strengths, limitations, and resultsThe Life Span Model of Suicide and Its Neurobiological Foundation.Suicidal ideation during antidepressant treatment: do genetic predictors exist?Integrative genomics strategies to elucidate the complexity of drug response.Endophenotypes as a measure of suicidality.Pharmacogenetics of mood disorders: what clinicians need to know.Genome-wide association studies in pharmacogenomics of antidepressants.Neuropathology of suicide: recent findings and future directions.Pharmacogenetics and Imaging-Pharmacogenetics of Antidepressant Response: Towards Translational Strategies.Multimarker analysis suggests the involvement of BDNF signaling and microRNA biosynthesis in suicidal behavior.The Impact of a Single Nucleotide Polymorphism in SIGMAR1 on Depressive Symptoms in Major Depressive Disorder and Bipolar Disorder.Genome-wide association study of increasing suicidal ideation during antidepressant treatment in the GENDEP project.Pharmacogenetics of SSRIs and Sexual Dysfunction.
P2860
Q24632901-60AF2B97-C848-43D5-A51B-135A260276A0Q27027537-83B8ABDD-5017-4DB5-BE32-4CBD8A4E3B7DQ28074917-9BE679A0-967C-436B-BF9C-FCCEE816A240Q28742939-C12699D6-826E-47F9-953C-BF2D241432AEQ33651168-0F77D091-3D5A-4276-9D67-1EC5E316C76FQ33912351-19702396-81BE-43C8-9FEE-7F2B73B44057Q34066818-8F72410D-9166-418F-A6A7-F2235E4997CDQ34155796-74C1ECFD-4EC0-4496-A203-85F682ADBE5FQ34415006-CC545ADE-9323-4572-B563-244477442707Q34424865-0C832CB4-B9AA-473A-B7C9-DC4DACE4204FQ34445375-CDC41E4C-8292-4F40-B93F-4A956DF3E6D3Q34726454-3319CB76-5EEE-4F38-BBB8-8B7D03EA874BQ35023117-4FF972B2-611C-4FD3-B9C6-D2CD2A005DEEQ35150183-0A396009-F7D2-4DFB-BC54-752965B4EB8BQ35217752-ED7C6173-14D3-4834-A532-EEA87D466B6FQ35226451-FC432D4E-9C41-49BA-96E1-8292EE6C2975Q35679930-2B1A4A1C-8104-4151-A478-B937BE9E90DEQ36234921-3E017CD3-915E-463B-BF06-DBD527FEFD5EQ36385728-5A348CCC-C103-4DD9-833D-5797C8E33B11Q36824657-30260406-4AE0-4615-9186-F2B4818B5A81Q37178537-4810F623-F978-4BC4-991D-34F148E79ED2Q37639841-C57228E3-6B2D-4C7D-81BC-8BB446C2743DQ37885976-2C1B3CF8-FA35-4286-8633-AF3BFAEE8C82Q37961088-0F62C0F7-3475-4E4A-937B-1AD09F7F8394Q38039966-4438BA40-20D4-4BDB-85DC-43645F3F0570Q38139479-80E760ED-C825-42B7-99E0-2A7FDE05E4A1Q38444447-E75F707B-08F4-43AB-8606-2587F6838590Q38659366-D4580915-4E4D-41D6-986A-12D741B2C0B1Q38983579-097BA5C5-CE51-49A8-B5E1-701EF71614F8Q39964346-D6F164B7-4128-42B8-8A03-78F48F0C0B5DQ47980447-008D1D05-C0ED-4E5A-B2D2-59C30501C8F0Q49024786-5A92C9F7-92E6-49A1-B795-26BB3669617EQ55506542-571C707D-D29A-4523-A740-4A652DE3CB33
P2860
Genome-wide association study of suicidal ideation emerging during citalopram treatment of depressed outpatients
description
2009 nî lūn-bûn
@nan
2009 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած
@hyw
2009 թվականի սեպտեմբերին հրատարակված գիտական հոդված
@hy
2009年の論文
@ja
2009年論文
@yue
2009年論文
@zh-hant
2009年論文
@zh-hk
2009年論文
@zh-mo
2009年論文
@zh-tw
2009年论文
@wuu
name
Genome-wide association study ...... tment of depressed outpatients
@ast
Genome-wide association study ...... tment of depressed outpatients
@en
Genome-wide association study ...... tment of depressed outpatients
@nl
type
label
Genome-wide association study ...... tment of depressed outpatients
@ast
Genome-wide association study ...... tment of depressed outpatients
@en
Genome-wide association study ...... tment of depressed outpatients
@nl
prefLabel
Genome-wide association study ...... tment of depressed outpatients
@ast
Genome-wide association study ...... tment of depressed outpatients
@en
Genome-wide association study ...... tment of depressed outpatients
@nl
P2093
P2860
P921
P3181
P1476
Genome-wide association study ...... tment of depressed outpatients
@en
P2093
A John Rush
Andrew S Allen
Gonzalo Laje
Husseini Manji
Nirmala Akula
P2860
P304
P3181
P356
10.1097/FPC.0B013E32832E4BCD
P407
P577
2009-09-01T00:00:00Z